ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,255.20
1.29%
Dow Jones
40,421.36
0.33%
Brent Oil
81.805
0.36%
Bitcoin
67,404.59
-0.30%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bellevue Life Sciences Acquisition Corporation (BLACU)

  7. Bellevue Life Sciences Acquisition Corporation (BLACU) News

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLACU
DateTimeSourceHeadlineSymbolCompany
07/16/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/21/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/13/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/08/20244:20PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/05/20241:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/16/20235:00PMPR Newswire (US)OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/16/20234:37PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/16/20234:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/15/20236:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/20234:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
10/20/20234:20PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
10/10/20235:00PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
08/14/20234:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
07/11/20234:58PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
07/11/20234:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
07/11/20234:45PMPR Newswire (US)Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business CombinationNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
06/28/20234:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
06/14/20235:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
05/22/20234:35PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
05/16/20238:01AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/31/20234:20PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/27/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/27/20234:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/27/20234:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/14/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
03/14/20234:05PMPR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/28/20235:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/23/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/21/20234:05PMPR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
02/14/20234:05PMPR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BLACU

Your Recent History

NASDAQ
EA
Electronic Arts
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved